Invention Grant
- Patent Title: RNA targeting in alpha-synucleinopathies
- Patent Title (中): RNA靶向于α-突触核蛋白病
-
Application No.: US13319022Application Date: 2010-05-06
-
Publication No.: US09255266B2Publication Date: 2016-02-09
- Inventor: Mary Maral Mouradian , Eunsung Junn
- Applicant: Mary Maral Mouradian , Eunsung Junn
- Applicant Address: US NJ New Brunswick
- Assignee: Rutgers, the State University of New Jersey
- Current Assignee: Rutgers, the State University of New Jersey
- Current Assignee Address: US NJ New Brunswick
- Agency: Fox Rothschild LLP
- International Application: PCT/US2010/033896 WO 20100506
- International Announcement: WO2010/129791 WO 20101111
- Main IPC: C12N15/113
- IPC: C12N15/113 ; A61K31/7105
Abstract:
Therapies and assays to screen for small molecules that can have therapeutic use in the control of neurodegenerative diseases such as Parkinson's and other alpha-synucleinopathies.
Public/Granted literature
- US20120129912A1 RNA Targeting in Alpha-Synucleinopathies Public/Granted day:2012-05-24
Information query
IPC分类:
